SCHEMBL22316605

SCHEMBL22316605

N#Cc1ccc(-c2ccccn2)c2sc3ccccc3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MIF P14174 1/20 0.41
▸ GABRA1 P14867 1/20 0.41
▸ KRAS P01116 1/20 0.41
▸ KDM4E B2RXH2 5/20 0.36
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ GLA P06280 2/20 0.36
▸ SLC22A12 Q96S37 5/20 0.35
▸ EGLN1 Q9GZT9 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ PRKCI P41743 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22316603 0.84 KRAS (0.38) MIFGABRA1KRASKDM4ENPC1
SCHEMBL24496743 0.83 LIMK1 (0.41) NPC1RAB9ASMN1; SMN2SLC22A12LMNA
SCHEMBL16838922 0.74 MIF (0.49) MIFGABRA1KRASKDM4ENPC1
SCHEMBL22315766 0.74 GRIA1 (0.39) MIFGABRA1KDM4ENPC1RAB9A
SCHEMBL26412294 0.73 GRM5 (0.39) KDM4ESMN1; SMN2HSD17B10METAP1TGFBR1
SCHEMBL22316604 0.72 GRM5 (0.41) MIFGABRA1KRASKDM4EALDH1A1
SCHEMBL22316613 0.72 PDE10A (0.42) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL22316614 0.72 PDE10A (0.36) KDM4ENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL22316612 0.72 PDE10A (0.38) KRASKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL31614324 0.71 MIF (0.49) MIFGABRA1KRASKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11785839-B2 Organic light-emitting materials containing cyano-substituted ligand Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-11785839-B2 Organic light-emitting materials containing cyano-substituted ligand Beijing Summer Sprout Technology Co., Ltd. (CN) 2023-10-10 — — US disclosed
US-20200251666-A1 ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND Beijing Summer Sprout Technology Co., Ltd. (CN) 2020-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251666-A1 ORGANIC LIGHT-EMITTING MATERIALS CONTAINING CYANO-SUBSTITUTED LIGAND L1CAM, CYBA, ICOSLG MIF 2263/4885GABRA1 821/4885KRAS 4698/4885
US-11785839-B2 Organic light-emitting materials containing cyano-substituted ligand L1CAM, CYBA, ICOSLG MIF 2263/4885GABRA1 821/4885KRAS 4698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback